| 货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
|---|---|---|---|---|
| rp174502-500μg |
500μg |
期货  |
| |
| rp174502-1mg |
1mg |
期货 |
|
| 产品名称 | macrophage migration inhibitory factor |
|---|---|
| 别名 | 巨噬细胞移动抑制因子 |
| 英文别名 | L-dopachrome isomerase | MMIF |
| 规格或纯度 | Moligand™ |
| CAS编号和信息 | rp174502 |
|---|
| 1. Lubetsky JB, Swope M, Dealwis C, Blake P, Lolis E. (1999) Pro-1 of macrophage migration inhibitory factor functions as a catalytic base in the phenylpyruvate tautomerase activity.. Biochemistry, 38 (22): (7346-54). [PMID:10353846] |
| 2. Hudson JD, Shoaibi MA, Maestro R, Carnero A, Hannon GJ, Beach DH. (1999) A proinflammatory cytokine inhibits p53 tumor suppressor activity.. J Exp Med, 190 (10): (1375-82). [PMID:10562313] |
| 3. Mitchell RA, Liao H, Chesney J, Fingerle-Rowson G, Baugh J, David J, Bucala R. (2002) Macrophage migration inhibitory factor (MIF) sustains macrophage proinflammatory function by inhibiting p53: regulatory role in the innate immune response.. Proc Natl Acad Sci USA, 99 (1): (345-50). [PMID:11756671] |
| 4. Cvetkovic I, Stosic-Grujicic S. (2006) Neutralization of macrophage migration inhibitory factor-novel approach for the treatment of immunoinflammatory disorders.. Int Immunopharmacol, 6 (10): (1527-34). [PMID:16919824] |
| 5. Shi X, Leng L, Wang T, Wang W, Du X, Li J, McDonald C, Chen Z, Murphy JW, Lolis E et al.. (2006) CD44 is the signaling component of the macrophage migration inhibitory factor-CD74 receptor complex.. Immunity, 25 (4): (595-606). [PMID:17045821] |
| 6. Flaster H, Bernhagen J, Calandra T, Bucala R. (2007) The macrophage migration inhibitory factor-glucocorticoid dyad: regulation of inflammation and immunity.. Mol Endocrinol, 21 (6): (1267-80). [PMID:17389748] |
| 7. Nguyen MT, Beck J, Lue H, Fünfzig H, Kleemann R, Koolwijk P, Kapurniotu A, Bernhagen J. (2003) A 16-residue peptide fragment of macrophage migration inhibitory factor, MIF-(50-65), exhibits redox activity and has MIF-like biological functions.. J Biol Chem, 278 (36): (33654-71). [PMID:12796500] |
| 8. Meyer-Siegler KL, Iczkowski KA, Leng L, Bucala R, Vera PL. (2006) Inhibition of macrophage migration inhibitory factor or its receptor (CD74) attenuates growth and invasion of DU-145 prostate cancer cells.. J Immunol, 177 (12): (8730-9). [PMID:17142775] |
| 9. Morand EF. (2005) New therapeutic target in inflammatory disease: macrophage migration inhibitory factor.. Intern Med J, 35 (7): (419-26). [PMID:15958113] |
| 10. Cherepkova OA, Lyutova EM, Eronina TB, Gurvits BY. (2006) Chaperone-like activity of macrophage migration inhibitory factor.. Int J Biochem Cell Biol, 38 (1): (43-55). [PMID:16099194] |
| 11. Thiele M, Bernhagen J. (2005) Link between macrophage migration inhibitory factor and cellular redox regulation.. Antioxid Redox Signal, 7 (9-10): (1234-48). [PMID:16115028] |
| 12. Binsky I, Haran M, Starlets D, Gore Y, Lantner F, Harpaz N, Leng L, Goldenberg DM, Shvidel L, Berrebi A et al.. (2007) IL-8 secreted in a macrophage migration-inhibitory factor- and CD74-dependent manner regulates B cell chronic lymphocytic leukemia survival.. Proc Natl Acad Sci USA, 104 (33): (13408-13). [PMID:17686984] |
| 13. Stosic-Grujicic S, Stojanovic I, Nicoletti F. (2009) MIF in autoimmunity and novel therapeutic approaches.. Autoimmun Rev, 8 (3): (244-9). [PMID:18721909] |
| 14. Bernhagen J, Krohn R, Lue H, Gregory JL, Zernecke A, Koenen RR, Dewor M, Georgiev I, Schober A, Leng L et al.. (2007) MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment.. Nat Med, 13 (5): (587-96). [PMID:17435771] |
| 15. Cho Y, Crichlow GV, Vermeire JJ, Leng L, Du X, Hodsdon ME, Bucala R, Cappello M, Gross M, Gaeta F et al.. (2010) Allosteric inhibition of macrophage migration inhibitory factor revealed by ibudilast.. Proc Natl Acad Sci USA, 107 (25): (11313-8). [PMID:20534506] |
| 16. Alampour-Rajabi S, El Bounkari O, Rot A, Müller-Newen G, Bachelerie F, Gawaz M, Weber C, Schober A, Bernhagen J. (2015) MIF interacts with CXCR7 to promote receptor internalization, ERK1/2 and ZAP-70 signaling, and lymphocyte chemotaxis.. FASEB J, 29 (11): (4497-511). [PMID:26139098] |
| 17. Thiele M, Kerschbaumer RJ, Tam FW, Völkel D, Douillard P, Schinagl A, Kühnel H, Smith J, McDaid JP, Bhangal G et al.. (2015) Selective Targeting of a Disease-Related Conformational Isoform of Macrophage Migration Inhibitory Factor Ameliorates Inflammatory Conditions.. J Immunol, 195 (5): (2343-52). [PMID:26209628] |
| 18. Richard V, Kindt N, Saussez S. (2015) Macrophage migration inhibitory factor involvement in breast cancer (Review).. Int J Oncol, 47 (5): (1627-33). [PMID:26412712] |
| 19. Schinagl A, Kerschbaumer RJ, Sabarth N, Douillard P, Scholz P, Voelkel D, Hollerweger JC, Goettig P, Brandstetter H, Scheiflinger F et al.. (2018) Role of the Cysteine 81 Residue of Macrophage Migration Inhibitory Factor as a Molecular Redox Switch.. Biochemistry, 57 (9): (1523-1532). [PMID:29412660] |
| 20. Trivedi-Parmar V, Jorgensen WL. (2018) Advances and Insights for Small Molecule Inhibition of Macrophage Migration Inhibitory Factor.. J Med Chem, 61 (18): (8104-8119). [PMID:29812929] |
| 21. Bucala R. (1994) Identification of MIF as a new pituitary hormone and macrophage cytokine and its role in endotoxic shock.. Immunol Lett, 43 (1-2): (23-6). [PMID:7737686] |
| 22. Bernhagen J, Calandra T, Mitchell RA, Martin SB, Tracey KJ, Voelter W, Manogue KR, Cerami A, Bucala R. (1993) MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia.. Nature, 365 (6448): (756-9). [PMID:8413654] |
| 23. Sun HW, Swope M, Cinquina C, Bedarkar S, Bernhagen J, Bucala R, Lolis E. (1996) The subunit structure of human macrophage migration inhibitory factor: evidence for a trimer.. Protein Eng, 9 (8): (631-5). [PMID:8875640] |
| 24. Rosengren E, Bucala R, Aman P, Jacobsson L, Odh G, Metz CN, Rorsman H. (1996) The immunoregulatory mediator macrophage migration inhibitory factor (MIF) catalyzes a tautomerization reaction.. Mol Med, 2 (1): (143-9). [PMID:8900542] |
| 25. Kleemann R, Mischke R, Kapurniotu A, Brunner H, Bernhagen J. (1998) Specific reduction of insulin disulfides by macrophage migration inhibitory factor (MIF) with glutathione and dihydrolipoamide: potential role in cellular redox processes.. FEBS Lett, 430 (3): (191-6). [PMID:9688536] |
| 26. Bloom J, Metz C, Nalawade S, Casabar J, Cheng KF, He M, Sherry B, Coleman T, Forsthuber T, Al-Abed Y. (2016) Identification of Iguratimod as an Inhibitor of Macrophage Migration Inhibitory Factor (MIF) with Steroid-sparing Potential.. J Biol Chem, 291 (51): (26502-26514). [PMID:27793992] |
首页
400-620-6333
